SENNA-S- docusate sodium and sennosides tablet, film coated 
Cypress Pharmaceutical, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Cypress Senna-S

Drug Facts

Active ingredients (in each tablet)

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purposes

Stool Softener

Laxative

Uses

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6-12 hours

Warnings

Do not use

  • if you are now taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN. IN CASE OF OVERDOSE, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

Directions

  • take preferably at bedtime or as directed by a doctor
AgeStarting DoseMaximum Dose
Adults and children 12 years and older2 tablets once a day4 tablets twice a day
Children 6 to under 12 years1 tablet once a day2 tablets twice a day
Children 2 to under 6 years½ tablet once a day1 tablet twice a day
Children under 2 yearsAsk a DoctorAsk a Doctor

Other information

  • Each tablet contains: Calcium 20 mg, Sodium 4 mg
  • Store at Controlled Room Temperature 15° - 30°C (59° - 86°F). Protect from light and moisture. Dispense in a tight, light-resistant container.

Inactive ingredients Croscarmellose Sodium, D&C Yellow #10, Dextrose, Dicalcium Phosphate, FD&C Yellow #6, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Silica, Sodium Benzoate, Stearic Acid, Titanium Dioxide.

Questions? If you have any questions or comments, or to report an adverse event or to obtain product information, call 1-800-793-2145.

Distributed by:
Cypress Pharmaceutical, Inc.
Morristown, NJ 07960

DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

NDC 60258-951-06

Senna-S
Laxative Tablets

Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each

Vegetable Laxative Ingredient Plus Stool Softener

Contains no ingredient made from a gluten-containing grain (wheat, barley, or rye).

CYPRESS PHARMACEUTICAL, INC.

60 Tablets

LAB-CY951-06 Front

LAB-CY951-06 Back

SENNA-S 
docusate sodium and sennosides tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:60258-951
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColororangeScoreno score
ShapeROUNDSize10mm
FlavorImprint Code G55
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:60258-951-0660 in 1 BOTTLE; Type 0: Not a Combination Product05/03/200206/30/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33405/03/200206/30/2020
Labeler - Cypress Pharmaceutical, Inc. (117055730)
Establishment
NameAddressID/FEIBusiness Operations
Gemini Pharmaceuticals055942270manufacture(60258-951)

Revised: 10/2021
Document Id: 22f2fe73-20c8-47ab-b2a3-e70d40f0a263
Set id: 8064bbeb-14a3-411c-8e86-e17ac9a7aa05
Version: 8
Effective Time: 20211028
 
Cypress Pharmaceutical, Inc.